PHARMA-BIO SERV, INC. Increase (Decrease) in Prepaid Expense and Other Assets
PHARMA-BIO SERV, INC. (PBSV) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$308.31 thousand for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-01-29
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-10-31 was $57.62K.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-07-31 was $17.86K, a 88.00% decline year-over-year.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-04-30 was $65.42K, a 471.18% increase year-over-year.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-01-31 was $11.53K, a 88.60% decline year-over-year.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$308.31K, a 1527.70% decline from fiscal 2024.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $21.59K, a 79.46% decline from fiscal 2023.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $105.13K, a 84.69% decline from fiscal 2022.
- PHARMA-BIO SERV, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $686.85K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2025-10-31 | -$308.31K 10-K · filed 2026-01-29 | ||||
| 2024-10-31 | $57.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-29 | $75.48K derived: sum of 2 quarters · filed 2026-01-29 | $140.90K derived: sum of 3 quarters · filed 2026-01-29 | $21.59K 10-K · filed 2026-01-29 | |
| 2024-07-31 | $17.86K 10-Q · filed 2024-09-16 | $83.28K derived: sum of 2 quarters · filed 2024-09-16 | -$36.03K 10-Q · filed 2024-09-16 | -$38.60K derived: sum of 4 quarters · filed 2025-01-29 | |
| 2024-04-30 | $65.42K 10-Q · filed 2024-06-14 | $53.89K 10-Q · filed 2024-06-14 | -$56.47K derived: sum of 3 quarters · filed 2025-01-29 | $92.38K derived: sum of 4 quarters · filed 2025-01-29 | |
| 2024-01-31 | $11.53K 10-Q · filed 2024-03-18 | -$121.88K derived: sum of 2 quarters · filed 2025-01-29 | $26.96K derived: sum of 3 quarters · filed 2025-01-29 | $38.41K derived: sum of 4 quarters · filed 2025-01-29 | |
| 2023-10-31 | -$133.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-29 | $15.43K derived: sum of 2 quarters · filed 2025-01-29 | $26.88K derived: sum of 3 quarters · filed 2025-01-29 | $105.13K 10-K · filed 2025-01-29 | -$105.13K 10-K · filed 2024-01-29 |
| 2023-07-31 | $148.84K 10-Q · filed 2024-09-16 | $160.29K derived: sum of 2 quarters · filed 2024-09-16 | $238.54K 10-Q · filed 2024-09-16 | ||
| 2023-04-30 | $11.45K 10-Q · filed 2024-06-14 | -$89.70K 10-Q · filed 2024-06-14 | |||
| 2023-01-31 | $101.15K 10-Q · filed 2024-03-18 | ||||
| 2022-10-31 | $686.85K 10-K · filed 2024-01-29 |